STOCK Act disclosures
IBRX ImmunityBio, Inc.
Members of Congress who traded or hold ImmunityBio, Inc., from their STOCK Act disclosures. None of the 13F managers we track hold it, so this page covers Congress only. IBRX earnings.
- 1 members traded it since Nov 22, 2023
- 2 / 0 buys / sales
- 0 held it at year end
- Sep 30, 2026 latest trade
Trades
2 trades since Nov 22, 2023, newest filings first
-
IBRXImmunityBio, Inc.Buy$1K–$15KTraded Sep 30Filed Oct 12 12d
-
IBRXImmunityBio, Inc.Buy$1K–$15KTraded Sep 28Filed Oct 12 14d
No trades match these filters.
Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. See all Congress trades and how we read these reports.